By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Lipocine Inc. 

675 Arapeen Drive
Suite 202
Salt Lake City  Utah  84108  U.S.A.
Phone: 801-994-7383 Fax:


Company News
Lipocine Inc. (LPCN) Announces Positive Phase 1b Top-Line Results With LPCN 1107 In Pregnant Women 1/12/2015 7:20:47 AM
FDA Confirms Lipocine Inc. (LPCN)'s Previously-Agreed Clinical Development Plan For LPCN 1021 12/15/2014 7:26:16 AM
Lipocine Inc. (LPCN) To Present At The Piper Jaffray 26th Annual Healthcare Conference 11/25/2014 11:07:08 AM
Lipocine Inc. (LPCN) Announces Management Changes 11/17/2014 2:29:25 PM
Lipocine Inc. (LPCN) Announces Financial And Operational Results For The Third Quarter Of 2014 11/10/2014 8:05:43 AM
Lipocine Inc. (LPCN) Announces Positive Top-Line Results In Phase 2a Study Of LPCN 1111 10/13/2014 7:13:16 AM
Lipocine Inc. (LPCN) Testosterone Therapy Meets Phase 3 Goals 9/24/2014 7:40:52 AM
Lipocine Inc. (LPCN) To Host Conference Call And Webcast To Discuss Top-Line Results From The Phase 3 Study Of LPCN 1021 9/24/2014 7:16:25 AM
Lipocine Inc. (LPCN) Announces First Patient Dosed In Phase 1 Study In Pregnant Women Of LPCN 1107, Potentially The First Oral Product For The Prevention Of Preterm Birth 9/9/2014 7:23:31 AM
Lipocine Inc. (LPCN) Announces Financial And Operational Results For The Second Quarter Of 2014 8/13/2014 3:54:45 PM